✦ LIBER ✦

What's hot from the ICS Annual Meeting 2006

✍ Scribed by Anand K. Patel; Christopher R. Chapple; Heinz Koelbl; Karl-Erik Andersson; Lori Birder

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 167 KB
Volume: 26
Category: Article
ISSN: 0733-2467
DOI: 10.1002/nau.20425

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What's hot from the ICS Annual Meeting 2

What's hot from the ICS Annual Meeting 2007

✍ A.K. Patel; C.R. Chapple 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

This is an editorial review which is intended to provide an overview of the meeting. By necessity it is not fully comprehensive and relates to the presented papers only. It contains inevitable bias which we have attempted to minimise as far as possible. These comments represent the personal views of

What's hot from the ICS annual meeting 2

What's hot from the ICS annual meeting 2008

✍ Hashim Hashim; Christopher Chapple 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

What was “hot” at the ICS annual meeting

What was “hot” at the ICS annual meeting San Francisco 2009

✍ Rufus Cartwright; Hashim Hashim; Christopher Chapple 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

What was hot at the ICS meeting Glasgow,

What was hot at the ICS meeting Glasgow, Scotland, 2011

✍ Rufus Cartwright; Altaf Mangera; Kari A.O. Tikkinen; Christopher Chapple 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

What was hot at the joint ICS and IUGA m

What was hot at the joint ICS and IUGA meeting Toronto, Canada, 23–27 August 2010

✍ Altaf Mangera; Rufus Cartwright; Kari A.O. Tikkinen; Christopher Chapple 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

The 12th Annual Meeting 2006 Japan Socie

The 12th Annual Meeting 2006 Japan Society of Gene Therapy

📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

Background: Cationic liposome-mediated interferon-beta (IFN-b) gene transfer has been found to induce regression of experimental glioma. We performed a pilot clinical trial to evaluate safety and effectiveness of this IFN-b gene therapy in five patients with malignant glioma (glioblastoma multiforme